Treatment Effects of Escitalopram (Lexapro) on Generalized Anxiety Disorder, Adherence to Antiretroviral Therapy,Cognition, and Immune Status Among Patients With HIV and AIDS: A 6-Week Open-Label, Prospective, Pilot Trial.
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2014
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- 08 Mar 2014 The treatment arm has been changed and primary endpoint has been added.
- 08 Mar 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 01 May 2009 New trial record